Clinical Trial Update: REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents [Phase 3]

View source ↗

Summary

A Phase 3 trial (REASSURE) evaluated the effect of rimonabant on HbA1c in overweight or obese adults with type 2 diabetes not adequately controlled on two oral …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rimonabant (rimonabant)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED